MedTrace Logo

Treatment of Pediatric Patients That Lost Sense of Smell Due to COVID-19

NCT04964414 · Status: TERMINATED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 20

Last updated 2024-06-13

Study results available
· View outcomes & findings →

Summary

This research study is a randomized controlled trial in pediatric and young adult patients who have lost their sense of smell due to COVID-19 viral infection. The goals are:

1. to learn more about the effects of smell retraining therapy on smell loss following COVID-19 and
2. to determine if budesonide-saline irrigations make smell retraining therapy more effective.

Conditions

  • Dysosmia
  • Anosmia
  • Covid19

Interventions

OTHER

Smell Retraining

Smell practice with household scented items

DRUG

Budesonide

Nasal irrigation with liquid steroid

Sponsors & Collaborators

  • Amanda Stapleton

    lead OTHER

Principal Investigators

  • Amanda L Stapleton, MD · University of Pittsburgh

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
21 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-30
Primary Completion
2023-01-13
Completion
2023-03-29
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04964414 on ClinicalTrials.gov